Industry Insights

31. Managing Risk In The Most Complex Combination Device Format 2/18/2026

    Autoinjectors add mechanical forces and interactions that change how container closure integrity must be evaluated. Learn why device complexity creates new risks and how testing strategies must adapt.

32. EO Sterilization In Transition: Regulatory Shifts And Industry Impact 2/17/2026

    Ethylene oxide sterilization is transforming. Manufacturers must adopt risk-based approaches and optimized cycles to meet rigorous emission controls and patient safety limits for sensitive populations.

33. Cybersecurity And Medical Devices: Understanding Classes And Risk 2/17/2026

    A device's FDA class fails to account for modern cyber exposure. Learn why software architecture and connectivity require independent security assessments to protect patient data and ensure compliance.

34. Part II: Defining The Dye Ingress Operating Window 2/12/2026

    Learn about the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.

35. Extractables And Leachables: A Critical Part Of CCS Under EU GMP Annex 1 2/4/2026

    Managing chemical migration from packaging and process equipment is essential to protect patient safety, maintain drug stability, and ensure regulatory compliance.

36. FAQs On The Revised EU GMP Annex 1: Volume 7 2/4/2026

    Modernize your sterile manufacturing approach. Explore essential insights on contamination control strategies, risk management, and barrier technologies to ensure full regulatory alignment.

37. FAQs On The Revised EU GMP Annex 1: Volume 8 2/4/2026

    Successfully implementing a site-wide CCS requires prioritizing barrier technologies, integrating primary packaging into risk assessments, and adopting a data-driven approach to environmental monitoring.

38. Part I: Defining The Dye Ingress Operating Window 2/4/2026

    Dye ingress testing depends on pressure dynamics that shift with viscosity. Discover how these constraints narrow its operating window and call into question its reliability for high‑risk applications.

39. Engineering Excellence In Container Closure Integrity Testing 1/30/2026

    Explore the critical factors that define a reliable container closure integrity method, as well as what truly distinguishes robust, reproducible testing in today’s demanding parenteral landscape.

40. A Holistic Approach To CCI Is A Deterministic Approach 1/30/2026

    A modern approach to CCI blends smart design, risk‑based strategies, and deterministic testing to safeguard sterile products. Learn how lifecycle thinking and practical sampling plans strengthen quality.